Restriction Spectrum Imaging Magnetic Resonance Imaging for Prostate Cancer

UCSD Moores Cancer Center, La Jolla, CA
Prostate CancerRestriction Spectrum Imaging Magnetic Resonance Imaging - Other
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial will test whether an MRI can predict how well a patient will respond to radiation therapy and androgen deprivation therapy for high-risk, localized prostate cancer.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 2

Similar Trials

1
Magnetic Resonance Spectroscopic Imaging
1
Positron emission tomography (PET)/magnetic resonance imaging (MRI)
1
Magnetic Resonance Imaging

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: within 18 months of RT completion

Month 18
PSA nadir within the 18 months after RT ≥0.5 ng/mL.
Year 3
Biochemical recurrence (PSA 2 ng/mL greater than nadir) within 3 years of completing RT.

Trial Safety

Phase-Based Safety

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Magnetic Resonance Spectroscopic Imaging
1
Positron emission tomography (PET)/magnetic resonance imaging (MRI)
1
Magnetic Resonance Imaging

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

RSI-MRI
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Restriction Spectrum Imaging Magnetic Resonance Imaging · No Placebo Group · Phase 2

RSI-MRI
Other
Experimental Group · 1 Intervention: Restriction Spectrum Imaging Magnetic Resonance Imaging · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 18 months of rt completion

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,050 Previous Clinical Trials
1,827,275 Total Patients Enrolled
5 Trials studying Prostate Cancer
670 Patients Enrolled for Prostate Cancer
Tyler Seibert, MD, PhDPrincipal Investigator - University of California, San Diego
University of California, San Diego
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Prostate Cancer
100 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are planning to receive radiation therapy with hormone treatment before and during the therapy.
References

Frequently Asked Questions

Is enrollment for this trial still open?

"This medical experiment, which was initially uploaded to clinicaltrials.gov on December 29th 2020 and updated as recently as May 16th 2022, is currently recruiting participants." - Anonymous Online Contributor

Unverified Answer

What is the total population size participating in this investigation?

"Affirmative. According to data hosted on clinicaltrials.gov, this medical experiment is currently enrolling patients. Initially posted in December 2020 and last edited in May 2022, the study seeks 100 participants across a single site." - Anonymous Online Contributor

Unverified Answer

Is Restriction Spectrum Imaging Magnetic Resonance Imaging a reliable diagnostic tool for patients?

"Our internal assessment of Restriction Spectrum Imaging Magnetic Resonance Imaging's safety resulted in a score of 2, as the technology has not yet been evaluated for efficacy but does possess some evidence regarding its safety." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top